Review: ACE-Is or ARBs reduce adverse CV outcomes regardless of baseline systolic blood pressure

Source Citation McAlister FA; Renin Angiotensin System Modulator Meta-Analysis Investigators. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensiv...